Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-08

Clinical Trial Update: A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in Children [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effectiveness and safety of topiramate for preventing migraines in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Migraine, Vascular Headaches | Phase 3 | Status: COMPLETED